This HTML5 document contains 55 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/chebi/
n20http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/pharmgkb/
n18http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/kegg-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/bindingdb/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/kegg-drug/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n17http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/drugbank/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/iuphar/
n4http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04272/identifier/guide-to-pharmacology/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/atc/
n8http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB04272
rdf:type
n3:Drug
n3:description
A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability. [PubChem]
n3:group
nutraceutical
owl:sameAs
n13:DB04272 n18:DB04272
dcterms:title
Citric Acid
adms:identifier
n6:CIT n7:C00158 n10:D00037 n11:14672 n14:2478 n15:2478 n16:30769 n17:DB04272 n20:PA449021
n3:synonym
2-Hydroxytricarballylic acid 3-Carboxy-3-hydroxypentane-1,5-dioic acid Citronensäure
n3:toxicity
ORAL (LD50): Acute: 5040 mg/kg [Mouse]. 3000 mg/kg [Rat].
n3:synthesisReference
Karl E. Wiegand, "Chemical process for producing citric acid." U.S. Patent US3962287, issued 0000.
n3:IUPAC-Name
n4:271B4AA1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4AA7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4AA6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4AA3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4AA4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4AA5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4A9F-363D-11E5-9242-09173F13E4C5 n4:271B4AB7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4AA0-363D-11E5-9242-09173F13E4C5 n4:271B4A9D-363D-11E5-9242-09173F13E4C5 n4:271B4AB9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4A9E-363D-11E5-9242-09173F13E4C5 n4:271B4ABA-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B4ABB-363D-11E5-9242-09173F13E4C5
n8:hasATCCode
n9:A09AB04
n3:H-Bond-Acceptor-Count
n4:271B4AAD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4AAE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4AA8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4AA9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4AAB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4AAA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4AAC-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
77-92-9
n3:category
n3:Bioavailability
n4:271B4AB3-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4AB5-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4AB6-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4AB8-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4AB2-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4AB1-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4AB4-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4AA2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4AAF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4AB0-363D-11E5-9242-09173F13E4C5